BioMarin Pharmaceutical, Inc. (BMRN)
64.08
+0.66
(+1.04%)
USD |
NASDAQ |
Feb 20, 16:00
64.69
+0.61
(+0.95%)
After-Hours: 05:50
BioMarin Pharmaceutical Total Assets (Quarterly) : 7.615B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 949.87M |
| Gilead Sciences, Inc. | 59.02B |
| Merck & Co., Inc. | -- |
| AbbVie, Inc. | 133.96B |
| Bristol Myers Squibb Co. | 90.04B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.558B |
| Shareholders Equity (Quarterly) | 6.057B |
| Debt to Equity Ratio | 0.1009 |
| Current Ratio | 4.828 |
| Net Debt Paydown Yield | 0.94% |